Document is current

Article History

Received: 8 August 2021

Accepted: 20 April 2022

First Online: 23 June 2022

Declarations

:

: The + ÀGIL Barcelona program study protocol and all its procedures were approved by the Clinical Research Ethics Committee of the Institut Universitari d’Investigació en Atención Primaria, Jordi Gol i Gorina (reference number 20/048-P) and Comisión de Ética en la Experimentación Animal y Humana, Universitat Autònoma de Barcelona (reference number CEEAH 5066). Before starting the telephone interview, oral informed consent was obtained from all participants after receiving the study’s information and the measures to guarantee their data confidentiality and protection, this consent was registered and noted in the same initial consent already collected face-ti-face, at the beginning of the + AGIL program.

: All participants provided written informed consent for study publication. Data collected has been exclusively used for the present study.

: Dra. Pérez has received honoraria for teaching activities by Nestlé, unrelated with the topic of the present work. Dr. Inzitari have also received honoraria by Nestlé for presenting at scientific meetings and serving as members of expert advisory boards, unrelated to the present work.